![Francis Sarena](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francis Sarena
Directeur des opérations chez
89BIO, INC.
Profil
Francis Willard Sarena is currently Chief Operating Officer at 89bio, Inc. since 2024.
Former positions include Chief Operating Officer at Apexigen America, Inc. from 2022 to 2023, President & Chief Operating Officer at Apexigen, Inc. in 2023, Chief Strategy Officer at Five Prime Therapeutics, Inc. from 2016 to 2021, Secretary, Vice President & General Counsel at Abbott Biotherapeutics Corp.
from 2008 to 2010, Secretary, Vice President & General Counsel at PDL BioPharma, Inc. in 2008, Principal at McCutchen, Doyle, Brown & Enersen LLP, Associate at BMC Partners LLP from 2000 to 2006.
Education includes an undergraduate degree from San Francisco State University in 1996 and a graduate degree from the University of California, Berkeley in 2000.
Postes actifs de Francis Sarena
| Sociétés | Poste | Début |
|---|---|---|
| 89BIO, INC. | Directeur des opérations | 05/08/2024 |
Anciens postes connus de Francis Sarena
| Sociétés | Poste | Fin |
|---|---|---|
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Directeur des opérations | 01/09/2023 |
| APEXIGEN, INC. | President | 23/07/2023 |
| FIVE PRIME THERAPEUTICS, INC. | Conseiller Juridique Général | 01/09/2016 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Conseiller Juridique Général | 01/07/2010 |
| PDL BIOPHARMA, INC. | Conseiller Juridique Général | 01/12/2008 |
Formation de Francis Sarena
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
BMC Partners LLP
 BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
McCutchen, Doyle, Brown & Enersen LLP
 McCutchen, Doyle, Brown & Enersen LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Health Technology |
89bio, Inc.
 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
Choisissez Zonebourse 
